Zhejiang Int'l Group (000411.SZ) stated on the investor interaction platform on June 27th that the company is a pharmaceutical distribution enterprise mainly engaged in the wholesale and retail business of pharmaceuticals and medical instruments, and has business cooperation with large pharmaceutical enterprises including Eli Lilly and Co and Novo-Nordisk A/S. At present, the company operates tens of thousands of varieties and specifications of pharmaceutical products, including hypoglycemic products, but the sales of specific single variety and specification account for a small proportion of the company's overall sales. The company will continue to pay attention to newly launched drugs and actively carry out relevant introduction work.
英特集团(000411.SZ)：与包括礼来、诺和诺德等在内的大型药企均有业务合作
Zhejiang Int'l Group (000411.SZ) has business collaborations with large pharmaceutical companies including Eli Lilly and Co, Novo-Nordisk A/S.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.